The Kaiser Permanente Center for Health Research was awarded $8.1 million from the National Institutes of Health (NIH) to conduct a novel clinical trial using whole genome sequencing to test women and their partners, before they actually conceive, for mutations that could cause rare, but serious diseases in their offspring.

The project is part of the Clinical Sequencing Exploratory Research…